Paul Andrea 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Paul Andrea
Chief Legal Officer
Transactions
- Award
Common Stock
2023-02-01+40,783→ 40,783 total - Award
Stock Option (Right to Buy)
2023-02-01+59,217→ 59,217 totalExercise: $23.65Exp: 2033-01-31→ Common Stock (59,217 underlying)
Footnotes (2)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.
- [F2]The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.